High levels of hospital-acquired infection on children's intensive care wards
Study shows high' rates of hospital-acquired infections among children in the UK and Europe.
The report, published in The Lancet infectious diseases, found that one in six children in paediatric intensive care units, and one in ten babies in neonatal intensive care units had developed hospital infections while being treated.
The study found that the pattern of hospital-acquired infections is different in babies and children compared to adults, with more serious infections such as blood poisoning/bloodstream infections being commonly seen (45%), followed by respiratory tract infections/pneumonia (22%).
Many of these hospital-related infections are also multi-drug resistant, making their treatment more complicated. The study was led by the European Centre for Disease Control (ECDC).
The authors, from St George's University of London and Imperial College London, are calling for continued action to prevent and reduce infection rates in children in hospital with a focus on neonatal and paediatric intensive care units.
Mike Sharland, Professor of Paediatric Infections at St George’s, University of London, commented: "These rates of hospital acquired infections are unacceptably high both in the UK and Europe, with worrying implications for babies, children and their families."
Alison Holmes, Professor of Infectious Diseases at Imperial College London added: "We urgently need focus and investment on reducing the risk of bloodstream infections in babies and children in intensive care units across Europe."
Public Health England, the Department of Health and NHS England have now launched a national Infection in Critical Care Quality Improvement Programme (ICCQIP) working with Adult, Paediatric and Neonatal Intensive Care societies and providers. This programme has the capacity to reduce these potentially avoidable infections, where hospitals collect data, develop and implement evidence-based interventions.
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.